Servier backs a Californian startup research project to accelerate therapeutic innovation
All the news from Servier Group
Servier presents its oncology activities at the ESMO Congress
Leukemia: research focused on targeted therapies
Hypertension and dyslipidemia: raising awareness and strengthening adherence with #BecauseISaySo
Guiding and supporting digestive cancer patients with MyJourney
Servier on the front line of cardiovascular disease prevention and therapeutic adherence
Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
Patient associations’ perception of pharmaceutical companies: Servier is making progress!